-
Loading metrics
Open Access
Peer-reviewed
Research Article
Development of a Tumor-Selective Approach to Treat Metastatic Cancer
-
Karen S. Aboody ,
*To whom correspondence should be addressed. E-mail: kaboody@coh.org (KSA); mary.danks@stjude.org (MKD)
Affiliation Divisions of Hematology/Hematopoietic Cell Transplantation and Neurosciences, and Department of Professional Education, City of Hope National Medical Center, Duarte, California, United States of America
⨯ -
Rebecca A. Bush,
Affiliation Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America
⨯ -
Elizabeth Garcia,
Affiliation Divisions of Hematology/Hematopoietic Cell Transplantation and Neurosciences, and Department of Professional Education, City of Hope National Medical Center, Duarte, California, United States of America
⨯ -
Marianne Z. Metz,
Affiliation Divisions of Hematology/Hematopoietic Cell Transplantation and Neurosciences, and Department of Professional Education, City of Hope National Medical Center, Duarte, California, United States of America
⨯ -
Joseph Najbauer,
Affiliation Divisions of Hematology/Hematopoietic Cell Transplantation and Neurosciences, and Department of Professional Education, City of Hope National Medical Center, Duarte, California, United States of America
⨯ -
Kristine A. Justus,
Affiliation Divisions of Hematology/Hematopoietic Cell Transplantation and Neurosciences, and Department of Professional Education, City of Hope National Medical Center, Duarte, California, United States of America
⨯ -
Doris A. Phelps,
Affiliation Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America
⨯ -
Joanna S. Remack,
Affiliation Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America
⨯ -
Karina Jin Yoon,
Affiliation Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America
⨯ -
Shanna Gillespie,
Affiliation Divisions of Hematology/Hematopoietic Cell Transplantation and Neurosciences, and Department of Professional Education, City of Hope National Medical Center, Duarte, California, United States of America
⨯ -
Seung U. Kim,
Affiliations Department of Medicine, University of British Columbia Hospital, Vancouver, British Columbia, Canada, Ajou University School of Medicine, Suwon, South Korea
⨯ -
Carlotta A. Glackin,
Affiliation Divisions of Hematology/Hematopoietic Cell Transplantation and Neurosciences, and Department of Professional Education, City of Hope National Medical Center, Duarte, California, United States of America
⨯ -
Philip M. Potter,
Affiliation Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America
⨯ -
Mary K. Danks
*To whom correspondence should be addressed. E-mail: kaboody@coh.org (KSA); mary.danks@stjude.org (MKD)
Affiliation Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America
⨯
Development of a Tumor-Selective Approach to Treat Metastatic Cancer
- Karen S. Aboody,
- Rebecca A. Bush,
- Elizabeth Garcia,
- Marianne Z. Metz,
- Joseph Najbauer,
- Kristine A. Justus,
- Doris A. Phelps,
- Joanna S. Remack,
- Karina Jin Yoon,
- Shanna Gillespie
- Published: December 20, 2006
- https://doi.org/10.1371/journal.pone.0000023